{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:55:47Z","timestamp":1761663347480},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dmidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.diagmicrobio.2015.02.005","type":"journal-article","created":{"date-parts":[[2015,2,20]],"date-time":"2015-02-20T05:16:52Z","timestamp":1424409412000},"page":"114-119","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Can serum level of HBsAg differentiate HBeAg-negative chronic hepatitis B from inactive carrier state?"],"prefix":"10.1016","volume":"82","author":[{"given":"Shahnaz","family":"Sali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidar","family":"Sharafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyede Hoda","family":"Alavian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Moayed","family":"Alavian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faranak","family":"Etesam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shima","family":"Salimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muayad A.","family":"Merza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Keshvari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0005","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/jmv.23790","article-title":"Correlation between hepatitis B virus surface antigen level and alpha-fetoprotein in patients free of hepatocellular carcinoma or severe hepatitis","volume":"86","author":"Akuta","year":"2014","journal-title":"J Med Virol"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0010","first-page":"281","article-title":"Hepatitis B virus infection in Iran: a systematic review","volume":"8","author":"Alavian","year":"2008","journal-title":"Hepat Mon"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0015","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4103\/1319-3767.121035","article-title":"Correlation between hepatitis B surface antigen titers and HBV DNA levels","volume":"19","author":"Alghamdi","year":"2013","journal-title":"Saudi J Gastroenterol"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0025","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0168-8278(01)00266-5","article-title":"Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study","volume":"36","author":"Brunetto","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0020","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/hep.22760","article-title":"Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B","volume":"49","author":"Brunetto","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0030","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1053\/j.gastro.2010.04.052","article-title":"Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers","volume":"139","author":"Brunetto","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0035","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/hep.23803","article-title":"A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B","volume":"52","author":"Chan","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0040","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1002\/hep.22884","article-title":"Hepatitis B virus DNA levels and outcomes in chronic hepatitis B","volume":"49","author":"Chen","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0045","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/hep.21811","article-title":"Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B","volume":"46","author":"Feld","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0050","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1053\/jhep.2001.27834","article-title":"Hepatitis B e antigen-negative chronic hepatitis B","volume":"34","author":"Hadziyannis","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0055","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0060","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jhep.2010.01.014","article-title":"Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective","volume":"52","author":"Jaroszewicz","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0065","doi-asserted-by":"crossref","first-page":"e15285","DOI":"10.5812\/hepatmon.15285","article-title":"How can we make decision for patients with chronic hepatitis B according to hepatitis B virus (HBV) DNA level?","volume":"14","author":"Keshvari","year":"2014","journal-title":"Hepat Mon"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0070","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1111\/liv.12345","article-title":"HBsAg quantification for identification of liver disease in chronic hepatitis B virus carriers","volume":"34","author":"Larsson","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0075","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2893.2003.00487.x","article-title":"Hepatitis B, virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures","volume":"11","author":"Lavanchy","year":"2004","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0080","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","article-title":"Hepatitis B virus infection","volume":"373","author":"Liaw","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0085","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jhep.2012.12.006","article-title":"A predictive scoring system for the seroclearance of HBsAg in HBeAg-seronegative chronic hepatitis B patients with genotype B or C infection","volume":"58","author":"Liu","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0090","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1056\/NEJM200205303462202","article-title":"Chronic hepatitis B","volume":"346","author":"Lok","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0095","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: update 2009","volume":"50","author":"Lok","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0100","first-page":"30","article-title":"Study of HBsAg escape mutations in chronic hepatitis B patients under treatment with nucleos(t)ide analogues","volume":"15","author":"Mahinrousta","year":"2012","journal-title":"Arak Med Univ J"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/135965350701200107","article-title":"Prediction of treatment-related HBsAg loss in HBeAg-negative chronic hepatitis B: a clue from serum HBsAg levels","volume":"12","author":"Manesis","year":"2007","journal-title":"Antivir Ther"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0110","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0168-8278(02)00004-1","article-title":"Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers","volume":"36","author":"Martinot-Peignoux","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0130","doi-asserted-by":"crossref","first-page":"S282","DOI":"10.1016\/S0168-8278(10)60727-1","article-title":"725 quantitative HBsAg: a new specific marker for the diagnosis of HBsAg inactive carriage","volume":"52","author":"Martinot-Peignoux","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0115","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jhep.2013.01.028","article-title":"Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naive, e antigen-positive patients","volume":"58","author":"Martinot-Peignoux","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0125","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jcv.2013.08.010","article-title":"Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA","volume":"58","author":"Martinot-Peignoux","year":"2013","journal-title":"J Clin Virol"},{"issue":"Suppl. 1","key":"10.1016\/j.diagmicrobio.2015.02.005_bb0120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/liv.12403","article-title":"HBsAg quantification: useful for monitoring natural history and treatment outcome","volume":"34","author":"Martinot-Peignoux","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0135","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.3748\/wjg.v9.i10.2322","article-title":"Healthy ranges of serum alanine aminotransferase levels in Iranian blood donors","volume":"9","author":"Mohamadnejad","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0140","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.22744","article-title":"Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients","volume":"49","author":"Moucari","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0145","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jhep.2010.01.007","article-title":"Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia","volume":"52","author":"Nguyen","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0150","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/01.meg.0000170926.83850.dd","article-title":"Serum hepatitis B virus DNA levels differentiating inactive carriers from patients with chronic hepatitis B","volume":"17","author":"Seo","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0155","doi-asserted-by":"crossref","first-page":"e43087","DOI":"10.1371\/journal.pone.0043087","article-title":"High hepatitis B surface antigen levels predict insignificant fibrosis in hepatitis B e antigen positive chronic hepatitis B","volume":"7","author":"Seto","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0160","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3851\/IMP1696","article-title":"Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B","volume":"15","author":"Su","year":"2010","journal-title":"Antivir Ther"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0165","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jcv.2014.01.013","article-title":"Clinical implications of hepatitis B surface antigen quantitation in the natural history of chronic hepatitis B virus infection","volume":"59","author":"Tan","year":"2014","journal-title":"J Clin Virol"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0170","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/hep.23571","article-title":"Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers","volume":"51","author":"Thompson","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0175","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/j.gastro.2012.02.007","article-title":"High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load","volume":"142","author":"Tseng","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0180","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1053\/j.gastro.2007.06.057","article-title":"Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients","volume":"133","author":"Volz","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.diagmicrobio.2015.02.005_bb0185","author":"World Health Organization (WHO)"},{"issue":"Suppl 1","key":"10.1016\/j.diagmicrobio.2015.02.005_bb0190","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1016\/S0168-8278(11)60400-5","article-title":"398 characterization of the inactive HBsAg carrier state with 3 year follow-up","volume":"54","author":"Yakut","year":"2011","journal-title":"J Hepatol"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889315000395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889315000395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T07:57:02Z","timestamp":1651305422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889315000395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0732889315000395"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2015.02.005","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can serum level of HBsAg differentiate HBeAg-negative chronic hepatitis B from inactive carrier state?","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2015.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}